Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 503
Active & Responsive
Understanding Perinatal Spinal Cord Injury
for
Perinatal Spinal Cord Injury
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 3 - 8
Code: NCT06808035
Recruiting
Active & Responsive
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for
Type 1 Diabetes
Location: Louisville KY, Cincinnati OH, Columbus OH, Chicago IL,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676565
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Louisville KY, Greenville SC, Atlanta GA, Decatur GA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase 2, Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Louisville KY, Nashville TN, Springfield IL,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: Louisville KY, Nashville TN, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07391657
Phase 3, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: Louisville KY, New Albany IN, Dayton OH, Des Plaines IL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Louisville KY, New Albany IN, Crestview Hills KY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
Active & ResponsiveNew
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations
for
SARS-CoV-2
Location: Louisville KY, Hendersonville TN, Charlotte NC,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT07863635
Phase 4, Recruiting
Active & Responsive
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
for
Post Traumatic Arthritis, Osteoarthritis,
Location: Louisville KY, South Bend IN, Morton Grove IL,
Sponsor: Stryker Trauma and Extremities
Sex: All
Age: 21+
Code: NCT07118501
Recruiting
Active & ResponsiveNew
A Study of Updated mRNA Seasonal Influenza Vaccines
for
Seasonal Influenza
Location: Louisville KY, Town and Country MO, Lenexa KS,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 65+
Code: NCT07884175
Phase 4, Recruiting
Active & Responsive
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies